CHRS vs CYTK: Correlation
Coherus Oncology, Inc. (CHRS) and Cytokinetics, Incorporated (CYTK) show a moderate relationship: their 3-year correlation of weekly returns is 0.42.
Data as of 2026-08-27 · refreshed every trading day · weekly returns · methodology
How correlated are CHRS and CYTK?
Across a 3-year window, the weekly returns of CHRS and CYTK correlate at 0.42, moderate. The past 12 months show a weaker link (0.15) than the 3-year average (0.42). Stretching to 5 years gives 0.41, with an annualized covariance of 3139.3 %².
Among the 13 assets we track against CHRS, CYTK ranks #4 by 3-year correlation. Their recent paths diverged sharply: over the last 12 months CYTK outperformed by 77.8 percentage points (+28.1% for CHRS against +105.9% for CYTK).
How is this computed?
Pearson correlation on weekly returns: ρ(A,B) = cov(rA, rB) / (σA · σB), over windows of 52, 156 and 260 weeks. Covariance is annualized (×52) and expressed in %². Full definitions on the methodology page.
CHRS vs CYTK: side by side
| CHRS (Coherus Oncology, Inc.) | CYTK (Cytokinetics, Incorporated) | |
|---|---|---|
| 1-year return | +28.1% | +105.9% |
| 5-year return | -90.8% | +138.5% |
| Volatility (ann.) | 102.6% | 73.4% |
| Beta vs S&P 500 | 1.59 | 0.92 |
| Max drawdown (3Y) | -87.7% | -72.4% |
| Market cap | $0.2B | $10.8B |
| P/E (trailing) | – | – |
| Dividend yield | 0.00% | 0.00% |
| Sector / category | US Listed | US Listed |
Year-by-year returns
| Year | CHRS | CYTK |
|---|---|---|
| 2022 | -50.4% | +0.5% |
| 2023 | -58.0% | +82.2% |
| 2024 | -58.6% | -43.7% |
| 2025 | +2.9% | +35.1% |
| 2026 | +2.8% | +22.6% |
Calendar-year price returns; the current year is year-to-date as of the data date above.
Are CHRS and CYTK good diversifiers for each other?
Reasonably. At 0.42, CHRS and CYTK keep a meaningful degree of independence, and combining them has historically reduced portfolio volatility.
FAQ
What is the correlation between CHRS and CYTK?
As of 2026-08-27, the correlation of weekly returns between CHRS and CYTK is 0.42 over 3 years, 0.15 over 1 year and 0.41 over 5 years.
Is CYTK a good diversifier for CHRS?
Reasonably. At 0.42, CHRS and CYTK keep a meaningful degree of independence, and combining them has historically reduced portfolio volatility.
What does a correlation of 0.42 mean?
Correlation ranges from −1 to +1. Values near +1 mean two assets move together, near 0 that they move independently, and negative values that they tend to move in opposite directions. It measures co-movement, not performance.
Use this data
$ curl https://www.pairbook.io/api/v1/pairs/chrs-vs-cytk.json
Drop this badge in a README or notebook; it updates with the data:
[](https://www.pairbook.io/pair/chrs-vs-cytk/)
No key needed, free to use. Full endpoint list in the API documentation.
Related comparisons
Hubs: CHRS correlations · CYTK correlations
